SAN ANTONIO--(BUSINESS WIRE)--Acelity today announced that it has acquired exclusive worldwide rights from The GID Group, Inc. for the REVOLVE™ System, a fat processing technology used in both reconstructive and cosmetic procedures to facilitate high-volume, autologous fat grafting. LifeCell Corporation, an Acelity Company, has held exclusive rights to distribute the REVOLVE™ System in the US and Canada since 2013. This new agreement provides LifeCell with worldwide rights for development, manufacturing and commercialization of the device.
Help employers find you! Check out all the jobs and post your resume.
